Secora Michael
Former Officer at RXRX
- Sold, on record
- $6.4M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Nov 13, 2024
- Form 144 notices
- 39
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- RXRXRECURSION PHARMACEUTICALS, INC.Former Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice RXRXNoticeNov 12, 2024 2024
Filed to sell 15,000 shares ($113k)
Secora Michael, Officer
10b5-1 plan0.3x usual sizeFiling
- 2 Form 144 notice RXRXNoticeNov 13, 2024 +1 day
Filed to sell 15,000 shares ($115k)
Secora Michael, Officer
10b5-1 plan0.3x usual sizeFiling
- 3 Form 4 sale RXRXRoutineNov 13, 2024 same day
Sold 30,000 shares at $7.65 ($230k)
Secora Michael, Chief Financial Officer
10b5-1 planSold 2% of holdings ($11.7M position)1.5M shares left0.6x usual sizeFollows a Form 144Filing
- 4 Form 144 notice RXRXNoticeDec 10, 2024 +27 days
Filed to sell 15,000 shares ($116k)
Secora Michael, Officer
10b5-1 planFirst sale on recordFiling
- 5 Form 144 notice RXRXNoticeDec 11, 2024 +1 day
Filed to sell 15,000 shares ($112k)
Secora Michael, Officer
10b5-1 planFirst sale on recordFiling
- 6 Form 144 notice RXRXNoticeJan 14, 2025 +34 days
Filed to sell 15,000 shares ($97k)
Secora Michael, Former Officer
10b5-1 plan0.3x usual sizeFiling
- 7 Form 144 notice RXRXNoticeJan 15, 2025 +1 day
Filed to sell 15,000 shares ($99k)
Secora Michael, Former Officer
10b5-1 plan0.3x usual sizeFiling
- 8 Form 144 notice RXRXNoticeJan 17, 2025 +2 days
Filed to sell 5,000 shares ($33k)
Secora Michael, Former Officer
No 10b5-1 plan0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (56)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | Jan 17, 2025 | RXRX | Former Officer | Form 144 notice | 5,000 | $33k | Notice | SEC | |
| Jan 15, 2025 | Jan 15, 2025 | RXRX | Former Officer | Form 144 notice | 15,000 | $99k | Notice | SEC | |
| Jan 14, 2025 | Jan 14, 2025 | RXRX | Former Officer | Form 144 notice | 15,000 | $97k | Notice | SEC | |
| Dec 11, 2024 | Dec 11, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $112k | Notice | SEC | |
| Dec 10, 2024 | Dec 10, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $116k | Notice | SEC | |
| Nov 13, 2024 | Nov 14, 2024 | RXRX | Chief Financial Officer | Form 4 sale | 30,000 | $230k | 2.0% | Routine | SEC |
| Nov 13, 2024 | Nov 13, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $115k | Notice | SEC | |
| Nov 12, 2024 | Nov 12, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $113k | Notice | SEC | |
| Oct 9, 2024 | Oct 10, 2024 | RXRX | Chief Financial Officer | Form 4 sale | 30,000 | $190k | 2.0% | Routine | SEC |
| Oct 9, 2024 | Oct 9, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $95k | Notice | SEC | |
| Oct 8, 2024 | Oct 8, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $95k | Notice | SEC | |
| Sep 11, 2024 | Sep 12, 2024 | RXRX | Chief Financial Officer | Form 4 sale | 30,000 | $187k | 2.1% | Routine | SEC |
| Sep 11, 2024 | Sep 11, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $95k | Notice | SEC | |
| Sep 10, 2024 | Sep 10, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $92k | Notice | SEC | |
| Aug 14, 2024 | Aug 15, 2024 | RXRX | Chief Financial Officer | Form 4 sale | 30,000 | $191k | 2.2% | Routine | SEC |
| Aug 14, 2024 | Aug 14, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $95k | Notice | SEC | |
| Aug 13, 2024 | Aug 13, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $95k | Notice | SEC | |
| Jul 10, 2024 | Jul 11, 2024 | RXRX | Chief Financial Officer | Form 4 sale | 30,000 | $218k | 2.2% | Routine | SEC |
| Jul 10, 2024 | Jul 10, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $109k | Notice | SEC | |
| Jul 9, 2024 | Jul 9, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $110k | Notice | SEC | |
| Jun 14, 2024 | Jun 17, 2024 | RXRX | Chief Financial Officer | Form 4 sale | 30,000 | $279k | 2.3% | Routine | SEC |
| Jun 14, 2024 | Jun 14, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $139k | Notice | SEC | |
| Jun 13, 2024 | Jun 13, 2024 | RXRX | Officer | Form 144 notice | 15,000 | $140k | Notice | SEC | |
| Apr 17, 2024 | Apr 18, 2024 | RXRX | Chief Financial Officer | Form 4 sale | 48,124 | $367k | 3.8% | Routine | SEC |
| Apr 17, 2024 | Apr 17, 2024 | RXRX | Officer | Form 144 notice | 23,124 | $175k | Notice | SEC | |
| Apr 16, 2024 | Apr 16, 2024 | RXRX | Officer | Form 144 notice | 25,000 | $192k | Notice | SEC | |
| Mar 13, 2024 | Mar 14, 2024 | RXRX | Chief Financial Officer | Form 4 sale | 50,000 | $537k | 4.0% | Routine | SEC |
| Mar 13, 2024 | Mar 13, 2024 | RXRX | Officer | Form 144 notice | 25,000 | $276k | Notice | SEC | |
| Mar 12, 2024 | Mar 12, 2024 | RXRX | Officer | Form 144 notice | 25,000 | $261k | Notice | SEC | |
| Feb 14, 2024 | Feb 15, 2024 | RXRX | Chief Financial Officer | Form 4 sale | 50,000 | $508k | 4.0% | Routine | SEC |
| Feb 14, 2024 | Feb 14, 2024 | RXRX | Officer | Form 144 notice | 25,000 | $261k | Notice | SEC | |
| Feb 13, 2024 | Feb 13, 2024 | RXRX | Officer | Form 144 notice | 25,000 | $247k | Notice | SEC | |
| Jan 17, 2024 | Jan 18, 2024 | RXRX | Chief Financial Officer | Form 4 sale | 50,000 | $518k | 4.8% | Routine | SEC |
| Jan 17, 2024 | Jan 17, 2024 | RXRX | Officer | Form 144 notice | 25,000 | $256k | Notice | SEC | |
| Jan 16, 2024 | Jan 16, 2024 | RXRX | Officer | Form 144 notice | 25,000 | $261k | Notice | SEC | |
| Dec 13, 2023 | Dec 14, 2023 | RXRX | Chief Financial Officer | Form 4 sale | 50,000 | $375k | 5.0% | Routine | SEC |
| Dec 13, 2023 | Dec 13, 2023 | RXRX | Officer | Form 144 notice | 25,000 | $186k | Notice | SEC | |
| Dec 12, 2023 | Dec 12, 2023 | RXRX | Officer | Form 144 notice | 25,000 | $189k | Notice | SEC | |
| Nov 15, 2023 | Nov 16, 2023 | RXRX | Chief Financial Officer | Form 4 sale | 50,000 | $341k | 5.1% | Routine | SEC |
| Nov 15, 2023 | Nov 15, 2023 | RXRX | Officer | Form 144 notice | 25,000 | $163k | Notice | SEC | |
| Nov 14, 2023 | Nov 14, 2023 | RXRX | Officer | Form 144 notice | 25,000 | $157k | Notice | SEC | |
| Oct 11, 2023 | Oct 12, 2023 | RXRX | Chief Financial Officer | Form 4 sale | 50,000 | $348k | 5.2% | Routine | SEC |
| Oct 11, 2023 | Oct 11, 2023 | RXRX | Officer | Form 144 notice | 25,000 | $176k | Notice | SEC | |
| Oct 10, 2023 | Oct 10, 2023 | RXRX | Officer | Form 144 notice | 25,000 | $170k | Notice | SEC | |
| Sep 13, 2023 | Sep 14, 2023 | RXRX | Chief Financial Officer | Form 4 sale | 50,000 | $428k | 5.3% | Routine | SEC |
| Sep 13, 2023 | Sep 13, 2023 | RXRX | Officer | Form 144 notice | 25,000 | $215k | Notice | SEC | |
| Sep 12, 2023 | Sep 12, 2023 | RXRX | Officer | Form 144 notice | 25,000 | $207k | Notice | SEC | |
| Aug 16, 2023 | Aug 17, 2023 | RXRX | Chief Financial Officer | Form 4 sale | 50,000 | $454k | 5.5% | Routine | SEC |
| Aug 16, 2023 | Aug 16, 2023 | RXRX | Officer | Form 144 notice | 25,000 | $228k | Notice | SEC | |
| Aug 15, 2023 | Aug 15, 2023 | RXRX | Officer | Form 144 notice | 25,000 | $231k | Notice | SEC |